{"result": "(\"entity\"<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>ORGANIZATION<|>La Fe Hospital Universitari i Politècnic is a medical institution that provides healthcare services and conducts research in various medical fields.)\n##\n(\"entity\"<|>AMERICAN GASTROENTEROLOGICAL ASSOCIATION<|>ORGANIZATION<|>The American Gastroenterological Association is a professional organization that focuses on advancing the science and practice of gastroenterology.)\n##\n(\"entity\"<|>M.D. HIGÓN BALLESTER<|>PERSON<|>M.D. Higón Ballester is a medical doctor who has contributed to the field of nutrition in inflammatory bowel disease.)\n##\n(\"entity\"<|>M. ARGENTE PLA<|>PERSON<|>M. Argente Pla is a medical doctor who has co-authored research on nutrition in inflammatory bowel disease.)\n##\n(\"entity\"<|>CROHN'S DISEASE<|>EVENT<|>Crohn's disease is a type of inflammatory bowel disease that can lead to malnutrition and other complications.)\n##\n(\"entity\"<|>ULCERATIVE COLITIS<|>EVENT<|>Ulcerative colitis is another form of inflammatory bowel disease that can result in nutritional deficiencies.)\n##\n(\"relationship\"<|>M.D. HIGÓN BALLESTER<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>M.D. Higón Ballester is associated with La Fe Hospital Universitari i Politècnic, contributing to its medical research and practices<|>7)\n##\n(\"relationship\"<|>M. ARGENTE PLA<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>M. Argente Pla is associated with La Fe Hospital Universitari i Politècnic, contributing to its medical research and practices<|>7)\n##\n(\"relationship\"<|>AMERICAN GASTROENTEROLOGICAL ASSOCIATION<|>CROHN'S DISEASE<|>The American Gastroenterological Association provides guidelines and research related to the management of Crohn's disease<|>6)\n##\n(\"relationship\"<|>AMERICAN GASTROENTEROLOGICAL ASSOCIATION<|>ULCERATIVE COLITIS<|>The American Gastroenterological Association provides guidelines and research related to the management of ulcerative colitis<|>6)\n##\n(\"relationship\"<|>CROHN'S DISEASE<|>M.D. HIGÓN BALLESTER<|>M.D. Higón Ballester has researched the nutritional implications of Crohn's disease<|>8)\n##\n(\"relationship\"<|>ULCERATIVE COLITIS<|>M. ARGENTE PLA<|>M. Argente Pla has researched the nutritional implications of ulcerative colitis<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2-1,5gAA/Kg/día con una relación Kcalnp/gn: 120:140.\n---\n## Tabla2\n\n| | |\n|---|---|\n| 1,5gAA/Kg/día | |\n| Harris-Benedict x ( 1,3-1,4) | |\n| Relación HC:LIP 60:40 | |\n| Kcalnp/gn: 120:140. | |\n\n-Valorar la administración de sodio para conseguir una correcta absorción de agua y nutrientes.\n\n- Si se reseca el íleon terminal se recomienda administrar vit. B12 im mensual.\n\n- A menudo se requiere suplementos de vitaminas hidrosolubles y liposolubles y oligoelementos, especialmente magnesio, calcio, zinc y selenio. (Tabla 3)\n\n| | |\n|---|---|\n| Vitamina A | 10000-50000 UI/día |\n| Vitamina B12 | 300 microgr im al mes en resecciones ileales |\n| Vitamina C | 200-500 mg/día |\n| Vitamina D | 1600 U DHT día o 25-OH o 1,23 ( Oh2)-D3 |\n| Vitamina E | 30UI día |\n| Vitamina K | 10 mg semanales |\n| Calcio | 800-1000mg al día |\n| Magnesio | 54 mg Mg elemental 3 - 4 veces / día |\n| Hierro | si se precisa |\n| Selenio | 60-100microg al día |\n| Zinc | 220-440mg al día |\n| Bicarbonato | si se precisa |\n---\n# INDICACIONES DE TRANSPLANTE INTESTINAL\n\nSe recomienda solo en pacientes que precisan tratamiento con NPT a muy largo plazo o que han desarrollado complicaciones con el tratamiento(fallo hepático, trombosis de 2 vías centrales, sepsis frecuente por catéter ( más de 2 infecciones por año), infección fúngica y episodios de deshidratación frecuentes.\n\n[A large logo at the bottom of the page reads \"La Fe Hospital Universitari i Politècnic\"]\n\n151\n---\n# BIBLIOGRAFÍA:\n\n1. American Gastroenterological Association. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1105-10.\n\n2. Byrne TA, Veglia L, Camelio M, Cox S, Anderson S, Wilson J, et al. Clinical Observations. Beyond the prescription: Optimizing the diet of patients with short bowel síndrome. Nutr Clin Pract. 2000;15:306-11.\n\n3. Nightingale JM, Walker ER, Farthing MJ, Lennard-Jones JE. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther. 1991;5:405-12.\n\n4. O'Keefe SJD, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: Consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4:6–10.\n\n5. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol. 2002;34:207-20.\n\n6. Wall EA. An overview of short bowel syndrome management: Adherence, adaptation, and practical recommendations. J Acad Nutr Diet. 2013;113: 1200-8.\n---\n# CAPITULO 19: NUTRICION EN ENFERMEDAD INFLAMATORIA INTESTINAL\n\nM.D. Higón Ballester, M. Argente Pla\n\n## 1. CONSIDERACIONES GENERALES\n\nEn la enfermedad inflamatoria intestinal(EII), tanto en la enfermedad de Crohn (EC) como en la colitis ulcerosa (CU), se detecta malnutrición calórico-proteica (MCP) y déficits de micronutrientes de origen multifactorial en una proporción elevada de pacientes.\n\nLa prevalencia de la malnutrición oscila entre 20-85% y esta variabilidad depende del tipo de enfermedad, la actividad de la misma y de los criterios empleados para su determinación.\n\nLa valoración del estado nutricional se puede realizar por los métodos tradicionales. La MCP suele ser consecuencia de:\n\n-Disminución de la ingesta oral condicionada por la clínica ( dolor, nauseas, hiporexia), el ayuno terapéutico, dietas restrictivas por intolerancia ( sin lácteos, sin residuos ).\n\n-Aumento de los requerimientos nutricionales secundarios al estrés, fiebre, inflamación y tratamiento esteroideo, etc.\n\n-Malabsorción de nutrientes ( secundaria a inflamación, cirugía, síndrome de intestino corto, sobrecrecimiento bacteriano), aumento de las perdidas proteicas, etc.\n\nConsecuencias generales de la malnutrición en la EII (tabla 1)\n\n| Consecuencias generales de la malnutrición en la EII |\n|-----------------------------------------------------|\n| • Inmunosupresión. |\n| • Retras\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}